Try our beta test site
2208 studies found for:    mds
Show Display Options
Rank Status Study
1 Recruiting Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)
Condition: Myelodysplastic Syndrome (MDS)
Intervention: Drug: Lenalidomide
2 Recruiting Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood
Conditions: Myelodysplastic Syndromes;   Juvenile Myelomonocytic Leukemia
Intervention:
3 Recruiting The National Myelodysplastic Syndromes (MDS) Study
Condition: Myelodysplastic Syndromes (MDS)
Intervention: Other: Therapeutic
4 Recruiting MDS-CAN: A Prospective National MDS Clinical Database and Local Tissue Bank
Condition: Myelodysplastic Syndrome (MDS)
Intervention:
5 Recruiting Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS)
Condition: Myelodysplastic Syndromes
Interventions: Behavioral: Question prompt list (QPL);   Behavioral: Education brochure of Groupe Français des Myélodysplasies
6 Completed Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del5q
Condition: Myelodysplastic Syndromes
Intervention: Drug: Lenalidomide
7 Completed Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndromes
Interventions: Drug: G-CSF;   Drug: Plerixafor;   Drug: Azacitidine
8 Unknown  Collection of Biological Data With Potential Prognostic Relevance in Patients With MYELODYSPLASTIC SYNDROMES
Condition: Myelodysplastic Syndrome
Intervention:
9 Recruiting Study of Clinical Efficacy and Safety of Tosedostat in MDS
Condition: Myelodysplastic Syndrome
Intervention: Drug: Tosedostat
10 Recruiting Study of DSP-7888 in Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: DSP-7888
11 Completed
Has Results
Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003
Condition: Myelodysplastic Syndrome
Intervention:
12 Active, not recruiting Trial of High Dose Lenalidomide in Patients With Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Trilineage Dysplasia (AML-TLD)
Condition: Myelodysplastic Syndrome
Intervention: Drug: Lenalidomide
13 Unknown  Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure
Conditions: Acute Myeloid Leukemia;   Chronic Myelomonocytic Leukemia;   Myelodysplastic Syndrome
Intervention: Drug: Decitabine
14 Completed Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
Conditions: Leukemia, Myeloid, Acute;   Myelodysplastic Syndromes
Intervention: Drug: Decitabine
15 Recruiting A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes (MDS)
Intervention: Other: No interventions
16 Terminated Velcade in Myelodysplastic Syndrome - Pilot Study
Condition: MDS
Intervention: Drug: Velcade
17 Active, not recruiting Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Other: blood samples
18 Unknown  Autoantibodies Against Human Recombinant Erythropoietin in Myelodysplatic Syndrome Patients
Condition: Myelodysplatic Syndrome
Intervention:
19 Active, not recruiting Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy
Condition: Myelodysplastic Syndrome
Intervention: Drug: Vosaroxin
20 Recruiting A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
Condition: AML and High Risk MDS
Interventions: Drug: LGH447;   Drug: LGH447 + midostaurin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.